From: The antihyperlipidemic activities of 4(3H) quinazolinone and two halogenated derivatives in rats
Parameters | HCD | HCD+B | HCD+Q | HCD+BrQ | HCD+IQ |
---|---|---|---|---|---|
Glucose(mg/dl) | Â | Â | Â | Â | Â |
Mean ± SD | 123.57 ± 11.99a | 109.20 ± 14.31b | 86.77 ± 9.87c | 95.80 ± 8.28c | 87.24 ± 5.32c |
Range | (105.11–135.02) | (82.69–125.22) | (77.45–106.22) | (86.36–111.10) | (77.54–93.81) |
Change% | - | -11.63 | -29.78 | -22.47 | -29.40 |
Total lipids(g/L) | Â | Â | Â | Â | Â |
Mean ± SD | 4.58 ± 0.67a | 3.75 ± 0.68b | 3.31 ± 0.95b | 3.13 ± 0.43b | 3.10 ± 0.78b |
Range | (3.62–5.67) | (2.82–4.79) | (2.02–4.54) | (2.40–3.90) | (2.17–4.72) |
Change% | - | -18.12 | -27.73 | -31.66 | -32.31 |
T.G.(mg/dl) | Â | Â | Â | Â | Â |
Mean ± SD | 94.46 ± 14.23a | 69.29 ± 11.04b | 87.05 ± 9.18ac | 78.56 ± 12.79bc | 79.59 ± 15.94bc |
Range | (73.33–108.89) | (54.40–86.65) | (75.56–102.22) | (66.67–98.50) | (52.44–100.89) |
Change% | - | -26.65 | -7.84 | -16.83 | -15.74 |
T.Cholesterol(mg/dl) | Â | Â | Â | Â | Â |
Mean ± SD | 159.06 ± 26.04a | 113.28 ± 17.52b | 95.55 ± 18.11bc | 93.19 ± 14.29bc | 89.35 ± 22.37c |
Range | (119.35–87.50) | (95.93–139.06) | (75.63–121.41) | (65.63–104.69) | (70.31–123.44) |
Change% | - | -28.78 | -39.93 | -41.41 | -43.83 |
F.Cholesterol(mg/dl) | Â | Â | Â | Â | Â |
Mean ± SD | 36.66 ± 7.14a | 37.88 ± 8.94a | 32.12 ± 8.15a | 29.45 ± 4.11a | 30.14 ± 6.39a |
Range | (25.76–45.20) | (29.59–52.36) | (21.14–46.18) | (22.11–33.82) | (25.04–40.33) |
Change% | - | 3.33 | -12.38 | -19.67 | -17.79 |
E.Cholesterol(mg/dl) | Â | Â | Â | Â | Â |
Mean ± SD | 122.40 ± 19.10a | 76.25 ± 8.89b | 63.93 ± 10.02bc | 65.05 ± 7.96bc | 60.25 ± 15.29c |
Range | (91.85–142.30) | (66.01–89.04) | (50.54–76.01) | (54.00–74.33) | (43.32–83.11) |
Change% | - | -37.7 | -47.77 | -46.85 | -50.78 |
HDL-C (mg/dl) | Â | Â | Â | Â | Â |
Mean ± SD | 24.27 ± 3.23 a | 27.73 ± 5.48a | 28.33 ± 6.15a | 25.68 ± 6.34a | 21.14 ± 8.93a |
Range | (19.75–28.80) | (18.30–35.15) | (20.36–36.00) | (18.92–33.32) | (14.44–37.84) |
Change% | - | 14.26 | 16.73 | 5.81 | -12.90 |
LDL-C (mg/dl) | Â | Â | Â | Â | Â |
Mean ± SD | 116.09 ± 26.74a | 71.32 ± 17.78 b | 52.20 ± 15.23b | 51.49 ± 10.43 b | 52.89 ± 19.31b |
Range | (74.82–141.75) | (49.96–89.66) | (32.83–76.84) | (29.54–62.17) | (26.84–79.28) |
Change% | - | -38.56 | -55.03 | -55.65 | -54.44 |
VLDL-C (mg/dl) | Â | Â | Â | Â | Â |
Mean ± SD | 18.89 ± 2.85a | 13.86 ± 2.21b | 17.41 ± 1.84ac | 15.71 ± 2.56bc | 15.92 ± 3.19bc |
Range | (14.67–21.78) | (10.88–17.33) | (15.11–20.44) | (13.33–19.70) | (10.49–20.18) |
Change% | - | -26.63 | -7.83 | -16.83 | -15.72 |
A.I. | Â | Â | Â | Â | Â |
Mean ± SD | 5.57 ± 0.87a | 3.27 ± 1.30b | 2.41 ± 0.42b | 2.79 ± 1.02b | 3.47 ± 0.91b |
Range | (4.22–7.21) | (1.80–6.11) | (1.94–3.14) | (1.67–4.52) | (2.26–4.70) |
Change% | - | -41.29 | -56.73 | -49.91 | -37.70 |